Philip Rackliffe's most recent trade in GE HealthCare Technologies Inc was a trade of 798 Common Stock, par value $0.01 per share done at an average price of $70.6 . Disclosure was reported to the exchange on Sept. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Tech | Philip Rackliffe | CEO, AIS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.56 per share. | 03 Sep 2026 | 798 | 41,533 | - | 70.6 | 56,307 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AIS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.23 per share. | 01 Sep 2026 | 340 | 42,331 | - | 71.2 | 24,218 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AIS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.23 per share. | 01 Sep 2026 | 290 | 42,897 | - | 71.2 | 20,657 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AIS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.23 per share. | 01 Sep 2026 | 226 | 42,671 | - | 71.2 | 16,098 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AIS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 16,458 | 43,187 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 24,598 | 24,598 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 9,356 | 26,729 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 3,154 | 18,547 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.20 per share. | 12 Feb 2026 | 1,174 | 17,373 | - | 79.2 | 92,981 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.97 per share. | 01 Feb 2026 | 189 | 15,393 | - | 79.0 | 14,925 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 1,388 | 15,582 | - | 73.7 | 102,337 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 204 | 16,970 | - | 73.7 | 15,041 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 165 | 17,308 | - | 73.7 | 12,165 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 134 | 17,174 | - | 73.7 | 9,880 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,058 | 14,058 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,916 | 17,473 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 158 | 12,557 | - | 88.3 | 13,951 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Philip Rackliffe | CEO, AVS | 05 Nov 2024 | 900 | 12,715 | - | 87.6 | 78,867 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, Ultrasound & IGT | 01 Sep 2024 | 1,388 | 13,780 | - | 84.8 | 117,730 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, Ultrasound & IGT | 01 Sep 2024 | 165 | 13,615 | - | 84.8 | 13,995 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Philip Rackliffe | CEO, Ultrasound & IGT | 15 Aug 2024 | 6,203 | 6,203 | - | - | Employee Stock Option (right to buy) | ||
| GE HealthCare Tech | Philip Rackliffe | CEO, Ultrasound & IGT | 15 Aug 2024 | 2,051 | 15,168 | - | 0 | Common Stock, par value $0.01 per share |